Scarica l'app Stockscreener
34.14
4.85%
1.58
Dopo l'orario di chiusura:
34.33
0.19
+0.56%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$32.56
Aprire:
$31.82
Volume 24 ore:
1.68M
Relative Volume:
2.87
Capitalizzazione di mercato:
$1.74B
Reddito:
$276.26M
Utile/perdita netta:
$16.52M
Rapporto P/E:
110.92
EPS:
0.3078
Flusso di cassa netto:
$24.75M
1 W Prestazione:
+10.77%
1M Prestazione:
-3.45%
6M Prestazione:
+8.31%
1 anno Prestazione:
-22.95%
Intervallo 1D:
$31.28
$35.20
Intervallo di 1 settimana:
$28.95
$35.20
Portata 52W:
$28.95
$45.97
Vericel Corp Stock (VCEL) Company Profile
Nome
Vericel Corp
Settore
Industria
Telefono
(734) 930-5555
Indirizzo
64 SIDNEY ST., CAMBRIDGE, MA
Compare VCEL vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VCEL
Vericel Corp
|
34.14 | 1.74B | 276.26M | 16.52M | 24.75M | 0.3078 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Vericel Corp Stock (VCEL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-17 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-08-09 | Iniziato | Canaccord Genuity | Buy |
| 2024-06-20 | Iniziato | TD Cowen | Buy |
| 2024-01-25 | Aggiornamento | Truist | Hold → Buy |
| 2023-08-08 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2022-11-10 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-11-09 | Downgrade | Truist | Buy → Hold |
| 2022-10-14 | Ripresa | Stephens | Overweight |
| 2021-01-11 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-12-18 | Iniziato | Stephens | Overweight |
| 2020-09-17 | Iniziato | Truist | Buy |
| 2019-10-09 | Iniziato | H.C. Wainwright | Buy |
| 2019-02-28 | Downgrade | Needham | Buy → Hold |
| 2018-08-08 | Reiterato | Needham | Buy |
| 2018-07-16 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2018-04-04 | Iniziato | Leerink Partners | Outperform |
| 2018-03-06 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2018-03-06 | Reiterato | Needham | Buy |
| 2018-03-05 | Reiterato | BTIG Research | Buy |
| 2017-06-21 | Iniziato | BTIG Research | Buy |
| 2017-03-13 | Reiterato | Needham | Buy |
| 2016-12-22 | Iniziato | Piper Jaffray | Overweight |
| 2016-11-09 | Reiterato | Needham | Buy |
| 2016-04-05 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2016-03-11 | Aggiornamento | Needham | Hold → Buy |
Mostra tutto
Vericel Corp Borsa (VCEL) Ultime notizie
Vericel Corporation (VCEL) Stock forecasts - Yahoo Finance UK
VCEL SEC FilingsVericel 10-K, 10-Q, 8-K Forms - Stock Titan
Allspring Global Investments Holdings LLC Cuts Position in Vericel Corporation $VCEL - MarketBeat
Vericel Corporation (NASDAQ:VCEL) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Vericel at TD Cowen Conference: Strong Growth and Strategic Expansion By Investing.com - Investing.com India
Vericel at TD Cowen Conference: Strong Growth and Strategic Expansion - Investing.com
Vericel (VCEL) Secures Lucrative Contract with Health and Human Services - GuruFocus
MediWound and Vericel Secure Up to $197 Million BARDA Contract for NexoBrid® Procurement and Development - Quiver Quantitative
U.S. burn emergency stockpile gets NexoBrid in $197M BARDA pact - Stock Titan
[144] Vericel Corp SEC Filing - Stock Titan
Soleus discloses 2.55M Vericel shares (NASDAQ: VCEL) - Stock Titan
Vericel Corp (VCEL) Stock Price Quote Today & Current Price Chart - Capital.com
Vericel Corp (VCEL) Stock Price Quote Today & Current Price Chart | Capital.com Australia - capital.com
Quarterly Trades: Is Vericel Corporation in a bullish channel2026 Market Mood & Free Verified High Yield Trade Plans - baoquankhu1.vn
Market Wrap: Is Vericel Corporation stock forming a triangle pattern2026 Catalysts & Weekly Stock Performance Updates - baoquankhu1.vn
Vericel stock hits 52-week low at 29.21 USD By Investing.com - Investing.com Australia
Vericel (NASDAQ:VCEL) Stock Rating Upgraded by Wall Street Zen - MarketBeat
[Form 4] Vericel Corp Insider Trading Activity - stocktitan.net
Vericel (NASDAQ:VCEL) Hits New 52-Week LowWhat's Next? - MarketBeat
Vanguard disaggregates holdings; files 13G/A for Vericel (VCEL) - Stock Titan
Vericel stock hits 52-week low at 29.21 USD - Investing.com
Vericel Corp (NASDAQ:VCEL) Emerges as a Top Affordable Growth Pick - ChartMill
Vericel (NASDAQ:VCEL) Stock Price Down 4.9%Time to Sell? - marketbeat.com
Vericel corp director Hagen sells $486k in shares By Investing.com - Investing.com India
Vericel corp director Hagen sells $486k in shares - Investing.com
Vericel (VCEL) director sells 15,000 shares after option exercise - Stock Titan
Vericel Corporation $VCEL Position Increased by Congress Asset Management Co. - marketbeat.com
Vericel Corp ($VCEL) CEO 2025 Pay Revealed - Quiver Quantitative
[ARS] Vericel Corp SEC Filing - Stock Titan
VCEL Stock Price, Quote & Chart | VERICEL CORP (NASDAQ:VCEL) - ChartMill
Vericel Corp. Experiences Revision in Its Stock Evaluation Amid Market Challenges - Markets Mojo
What Makes Vericel Corporation (VCEL) an Investment Bet? - Yahoo Finance
Dilated Cardiomyopathy Market: Rapid Growth & Investment Outlook to 2034 – DelveInsight | Bristol Myers Squibb, Berlin Cures, Cumberland Pharma, Vericel Corp, Corimmun GmbH, Pfizer, Constant Therapeut - Barchart
Dilated Cardiomyopathy Market: Rapid Growth & Investment - openPR.com
Bank Watch: Can Vericel Corporation sustain earnings growth2026 Recap & Safe Entry Point Alerts - baoquankhu1.vn
Vericel at Leerink Global Healthcare: Strategic Growth and Expansion By Investing.com - Investing.com Australia
Vericel at Leerink Global Healthcare: Strategic Growth and Expansion - Investing.com South Africa
Leerink reiterates Outperform on Vericel stock, $46 target - Investing.com
FDA MACI Approval Tests Vericel’s Capacity Plans And Growth Story - Yahoo Finance
Vericel Corporation (VCEL) Secures FDA Approval for Commercial Manufacturing of MACI - Finviz
Vericel (VCEL) Valuation In Focus After FDA Clears MACI Commercial Manufacturing Capacity - simplywall.st
Vericel (NASDAQ:VCEL) Downgraded by Wall Street Zen to Hold - MarketBeat
Vericel (VCEL) Is Down 9.8% After FDA Clears New MACI Plant – Has The Bull Case Changed? - simplywall.st
Vericel wins FDA approval for MACI production at new facility - Investing.com
Insider Sell: Michael Halpin Sells 10,305 Shares of Vericel Corp (VCEL) - GuruFocus
Vericel wins FDA approval for MACI production at new facility By Investing.com - Investing.com Canada
Vericel (VCEL) COO sells 10,305 shares in automatic Rule 10b5-1 trade - Stock Titan
Vericel Corp Azioni (VCEL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):